Skip to main content
Equibles

BARCLAYS PLC

Position in SPRY — ARS Pharmaceuticals, Inc.

CIK 312069 LONDON, X0
Back to SPRY Full portfolio

Position in SPRY

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,011,349
+$335,474 QoQ
Shares Held
126,261
+50.0% QoQ
Ownership
0.127%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#52
of 208 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SPRY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,710,275,600 across 455 Biotechnology names. SPRY ranks #117 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 733,274 $364,239,192
2 REGN
Regeneron Pharmaceuticals, Inc.
 256,192 $159,745,957
3 IONS
Ionis Pharmaceuticals Inc
 1,603,136 $127,112,653
4 ARGX
Argenx SE
 134,427 $124,717,337
5 MRNA
Moderna, Inc.
 1,035,126 $72,489,872
6 BBIO
BridgeBio Pharma, Inc.
 714,423 $53,210,224
7 TGTX
Tg Therapeutics, Inc.
 957,848 $52,624,168
8 DNTH
Dianthus Therapeutics, Inc. /DE/
 431,753 $42,087,281

All Filings in SPRY

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,011,349 126,261
2026-03-31 $675,875 84,169
2025-12-31 $2,287,907 196,387
2025-09-30 $2,297,118 228,569
2025-06-30 $10,858,000 622,235
2025-03-31 $1,660,999 132,035
2024-12-31 $1,668,799 158,180
2024-09-30 $1,619,157 111,666
2024-06-30 $327,966 38,539
2024-03-31 $305,302 29,873
2023-12-31 $221,249 40,374
2023-09-30 $67,197 17,777
2023-06-30 $137,082 20,460
2023-03-31 $232,940 35,782
2022-12-31 $177,509 20,810
2022-09-30 $105,520 19,985
2022-06-30 $88,603 20,897
2022-03-31 $60,038 17,105